Business Daily Media

Men's Weekly

.

Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

  • Written by PR Newswire
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre Fabre Medical Care R&D teams. The study...

More Articles ...

  1. OrbusNeich® Medical and P+F Products & Features® announce new partnership-PR Newswire APAC
  2. The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
  3. Global Beauty & Wellness Awards announces Best Cosmetics and Hotels in the World 2020-PR Newswire APAC
  4. Centennial Property Group Announces Offering of AUD$100Million Senior Secured Loan Note Program-PR Newswire APAC
  5. ASEAN Marketing Summit 2020 -- The Biggest Marketing Summit in ASEAN is Back-PR Newswire APAC
  6. Amcor reports strong first quarter results and raises outlook for fiscal 2021-PR Newswire APAC
  7. Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
  8. New football simulator Football for Friendship World to be released on World Football Day
  9. FP Markets recognised as 'Best FX Broker Australia' for 2020
  10. Fuji Xerox Strengthens Synergies Within Fujifilm Group to Create Growth Globally-PR Newswire APAC

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

Sell by LayBy